04/06/2024
Have you ever heard of Extramammary Paget's Disease (EMPD)? Do you know that -directed therapies may also help with this ultra-rare disease in its advanced stages? Yes - this is the same "HER2" in common breast cancers. Here, Lim BY et al. characterized the entire tumor DNA sequence of HER2-positive EMPD using whole genome sequencing (the world's first!) and demonstrated how HER2-targeted therapies can be used to help patients with this cancer.
Background Extramammary Paget’s disease (EMPD) is a rare cancer that occurs within the epithelium of the skin, arising predominantly in areas with high apocrine gland concentration such as the v***a, sc***um, p***s and perianal regions. Here, we aim to integrate clinicopathological data with genom...